Congratulations to Risen for being listed on the "Hurun Global Cheetahs Index 2024"

Congratulations to Risen and its chairman Jiasheng Lv, Ph.D. for being listed on the （Baoding International Medical Base · Hurun China Healthcare Pioneering Young Start-ups 2024）and（Baoding International Medical Base ·

PI3K-α inhibitor RP903 tablets have been approved for two additional PROS pediatric rare disease clinical trials.

Risen Pharma and Maiwei Biotech have signed a licensing agreement to jointly promote the development of drugs in the field of bone health.

Risen Pharma has entered into a comprehensive strategic cooperation agreement with the Shanghai Center for Infectious Diseases and Immune Innovation.

Risen's innovative KRAS drug research result has been selected for presentation at the AACR Annual Meeting 2024 in San Diego, California!